Grupo Bimbo Recognized as One of the World’s Most Ethical Companies for 8th Consecutive Year
March 04, 2024 12:43 ET
|
Bimbo Bakeries
Grupo Bimbo was one of 136 companies from 20 countries and 44 industries to be recognized in 2024.The World's Most Ethical Companies assessment includes more than 240 questions on culture,...
Grupo Bimbo Celebrates Its 6 Time Honoree Recognition as One of the 2022 World's Most Ethical Companies
March 31, 2022 12:20 ET
|
Bimbo Bakeries
HORSHAM, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- Grupo Bimbo, the largest baking company in the world, has been recognized for the sixth time by Ethisphere, a global leader in defining and advancing...
Novartis pledges 10-year commitment with Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and other leading organizations to co-create effective, measurable solutions for health equity
July 20, 2021 07:05 ET
|
Novartis Pharma AG
Novartis and the Novartis US Foundation to join forces with Thurgood Marshall College Fund, Morehouse School of Medicine, 26 other Historically Black Colleges, Universities and Medical Schools and...
Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19
December 14, 2020 01:15 ET
|
Novartis International AG
Phase III study did not meet its primary endpoint of reducing the number of hospitalized COVID-19 patients who experienced severe complications (death, mechanical ventilation or ICU care)1 Detailed...
Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
September 01, 2020 01:00 ET
|
Novartis International AG
2025 target to increase patients reached in LMICs with strategic innovative medicines by 200% and the Novartis Flagship Programs by 50% - bringing potential reach to over 23 million patients across...
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
July 16, 2020 01:15 ET
|
Novartis International AG
Portfolio of 15 generic and over-the-counter (OTC) medicines from Sandoz division addresses urgent unmet needs of low- and lower-middle-income countries to treat patients with COVID-19...
Novartis resolves legacy litigation matters, finalizing settlement of speaker program litigation with Government in the US and positioning company for the future by fully scaling its next-generation digital engagement technologies
July 02, 2020 18:41 ET
|
Novartis International AG
Company finalizes USD 678 million settlement relating to suit challenging speaker programs and other promotional events conducted from 2002 through 2011 in the US as well as USD 51.25 million related...
Novartis Resolves Legacy FCPA Investigations
June 25, 2020 13:11 ET
|
Novartis International AG
Basel, June 25, 2020 – Novartis has reached settlements with the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) resolving all Foreign Corrupt Practices Act (FCPA)...